Use of methotrexate in inflammatory bowel disease in 2014: A User&rsquo;s Guide

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

396

WORD

387

HTML

2434

Figures (1-1)

282

Tables (1-3)

232

Sum=3731

Aug 6, 2014 (publication date) through Nov 4, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Pharmacol Ther. Aug 6, 2014; 5(3): 113-121
Published online Aug 6, 2014. doi: 10.4292/wjgpt.v5.i3.113

Figure 1 Algorithm for evidence-based use of methotrexate in inflammatory bowel disease. AZA: Azathioprine.

Citation: Swaminath A, Taunk R, Lawlor G. Use of methotrexate in inflammatory bowel disease in 2014: A User’s Guide. World J Gastrointest Pharmacol Ther 2014; 5(3): 113-121
URL: https://www.wjgnet.com/2150-5349/full/v5/i3/113.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v5.i3.113